Monday, December 13: 1-2 p.m. ET
The Association of Clinicians for the Underserved and Pfizer held a free webinar on the importance of community engagement to diversify clinical trials and improve health equity on Monday, December 13, at 1 p.m. ET. By ensuring diversity in clinical trials, we can develop safer, more effective vaccines and medicines for patients of diverse racial and ethnic backgrounds, including those disproportionately affected by certain diseases. Yet barriers to clinical trial diversity, such as lack of access, medical mistrust, and other factors present challenges to this vital initiative.
This free webinar explored this issue and best practices for engaging our communities to diversify representation in clinical trials. Niesha Foster, Vice President, Product Access, Global Health, and Social Impact at Pfizer, offered a discussion which:
- Explored current participation rates of racial and ethnic groups in clinical trials, data gaps, and why diversity in clinical trials matters
- Provided guidance on community engagement to address issues of medical mistrust
- Shared Pfizer’s approach to community engagement for the COVID-19 vaccine clinical trial in the U.S.Detail COVID-19’s impact on social determinants of health and suicidality, and why providers and staff at health centers and other facilities can play important roles in prevention.
Want to be informed about other upcoming webinars on health equity for underserved populations? Join our mailing list!
Presenter
- Niesha Foster, Vice President, Product Access, Global Health & Social Impact, Pfizer
More Resources on Clinical Trial Diversity
Curious to learn more about the importance of diversity in clinical trials? Read our blog post on how increasing diversity helps to develop better medicines and vaccines while improving health equity, or browse our recent webinar series on Building an Inclusive Organization to learn more about justice, equity, diversity, and inclusion at federally qualified health centers and beyond.
